- Investing Ideas
- /
- Pakistani Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Pakistani Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
8
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
8 companies
Citi Pharma
Market Cap: PK₨22.8b
Engages in the manufacture and sale of pharmaceutical, medical chemical, and botanical products in Pakistan.
CPHL
PK₨101.64
7D
18.7%
1Y
312.8%
Abbott Laboratories (Pakistan)
Market Cap: PK₨106.3b
Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.
ABOT
PK₨1,074.12
7D
1.6%
1Y
102.7%
Liven Pharmaceuticals
Market Cap: PK₨8.1b
Manufactures and markets pharmaceutical products in Pakistan.
LIVEN
PK₨86.91
7D
2.5%
1Y
769.1%
GlaxoSmithKline Pakistan
Market Cap: PK₨142.0b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨468.40
7D
16.2%
1Y
404.9%
Highnoon Laboratories
Market Cap: PK₨50.5b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨980.49
7D
9.3%
1Y
73.1%
BF Biosciences
Market Cap: PK₨13.9b
A diversified biotech pharmaceutical company, manufactures, imports, and sells pharmaceutical products.
BFBIO
PK₨158.10
7D
2.9%
1Y
n/a
Hoechst Pakistan
Market Cap: PK₨32.0b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨3,233.01
7D
0.9%
1Y
148.7%
Otsuka Pakistan
Market Cap: PK₨2.2b
Manufactures, markets, and distributes intravenous infusions in Pakistan and Afghanistan.
OTSU
PK₨185.28
7D
4.5%
1Y
44.2%